We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.5B
AUM Growth
+$857M
Cap. Flow
+$670M
Cap. Flow %
14.88%
Top 10 Hldgs %
17.64%
Holding
512
New
198
Increased
109
Reduced
79
Closed
118

Sector Composition

Rank Sector Weight
1 Healthcare 13.99%
2 Industrials 12.65%
3 Financials 10.63%
4 Consumer Discretionary 9.16%
5 Energy 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZWS icon
201
Zurn Elkay Water Solutions
ZWS
$8.68B
$6.42M 0.14%
+473,089
New +$6.29M
CLNY
202
DELISTED
Colony Capital, Inc.
CLNY
$6.39M 0.14%
+275,000
New +$6.04M
BERY
203
DELISTED
Berry Global Group, Inc.
BERY
$6.36M 0.14%
+268,252
New +$5.86M
DG icon
204
Dollar General
DG
$28.3B
$6.3M 0.14%
109,898
-37,609
-25% -$2.15M
RITM icon
205
Rithm Capital
RITM
$5.59B
$6.3M 0.14%
+500,000
New +$6.34M
DDD icon
206
3D Systems Corp
DDD
$601M
$6.26M 0.14%
+104,614
New +$5.37M
HRL icon
207
Hormel Foods
HRL
$13.8B
$6.24M 0.14%
+252,966
New +$6.11M
MRD
208
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
$6.15M 0.14%
+252,381
New +$6.07M
KKR icon
209
KKR & Co
KKR
$92.9B
$6M 0.13%
246,390
-50,788
-17% -$1.18M
OMED
210
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$5.83M 0.13%
250,434
-11,329
-4% -$280K
OXFD
211
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$5.83M 0.13%
346,562
+16,129
+5% +$290K
ACSF
212
DELISTED
American Capital Senior Floating, Ltd.
ACSF
$5.79M 0.13%
413,487
-109,367
-21% -$1.5M
CNX icon
213
CALL
CNX Resources
CNX
$5.19B
$5.76M 0.13%
+150,000
New +$5.5M
CMP icon
214
Compass Minerals
CMP
$1.03B
$5.75M 0.13%
60,115
-234,397
-80% -$21.1M
HUBG icon
215
HUB Group
HUBG
$2.8B
$5.69M 0.13%
+225,824
New +$5.15M
RALY
216
DELISTED
RALLY SOFTWARE DEV CORP
RALY
$5.67M 0.13%
521,040
+174,431
+50% +$2.17M
HF
217
DELISTED
HFF Inc.
HF
$5.58M 0.12%
+150,000
New +$4.99M
MJN
218
DELISTED
Mead Johnson Nutrition Company
MJN
$5.46M 0.12%
+58,587
New +$5.12M
WP
219
DELISTED
Worldpay, Inc.
WP
$5.41M 0.12%
+160,889
New +$4.96M
HSH
220
DELISTED
HILLSHIRE BRANDS CO
HSH
$5.39M 0.12%
86,500
-262,463
-75% -$11.9M
MTN icon
221
CALL
Vail Resorts
MTN
$5.28B
$5.36M 0.12%
+69,400
New +$4.87M
FURX
222
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$5.35M 0.12%
+50,366
New +$4.94M
BV
223
DELISTED
Bazaarvoice, Inc.
BV
$5.33M 0.12%
675,489
+60,153
+10% +$421K
PRTA icon
224
Prothena Corp
PRTA
$439M
$5.3M 0.12%
+235,000
New +$5.88M
WEC icon
225
WEC Energy
WEC
$35.2B
$5.29M 0.12%
+112,800
New +$5.24M

Similar funds

Alyeska Investment Group's Q2 2014 Portfolio in Review

As of Q2 2014, Alyeska Investment Group held 512 positions worth $4.5B, up 24% from $3.64B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $670M of net new capital in Q2 2014, opening 198 new positions and adding to 109 existing holdings. Its largest new stake was Amsurg Corp: 1,600,000 shares worth $72.9M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Pinnacle Foods, Inc., an estimated $34.3M trimmed.

  • Alyeska Investment Group's largest Q2 2014 buy was Amsurg Corp: 1,600,000 shares worth $72.9M.
  • Alyeska Investment Group added most to Capital One in Q2 2014, an estimated $18.5M increase.
  • Alyeska Investment Group's biggest Q2 2014 reduction was Pinnacle Foods, Inc., cutting an estimated $34.3M.
  • Alyeska Investment Group fully exited Pfizer in Q2 2014, selling an estimated $32.3M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.5B portfolio in Q2 2014.
  • Alyeska Investment Group opened 198 new positions and closed 118 in Q2 2014.
  • Alyeska Investment Group's portfolio value rose 24% quarter-over-quarter to $4.5B.

Based on Alyeska Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.